Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 13/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.42 |
| ▸ | RXRA | P19793 | 3/20 | 0.41 |
| ▸ | RXRB | P28702 | 3/20 | 0.41 |
| ▸ | RXRG | P48443 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7503849 | 0.92 | PTGS2 (0.47) | PTGS2ALDH1A1LMNAMAPTPTGS1 | |
| SCHEMBL7506418 | 0.91 | MAPT (0.44) | PTGS2ALDH1A1LMNAMAPTPTGS1 | |
| SCHEMBL7503574 | 0.91 | PTGS2 (0.46) | PTGS2ALDH1A1LMNAMAPTPTGS1 | |
| SCHEMBL7504876 | 0.90 | PTGS2 (0.49) | PTGS2PTGS1RXRARXRBRXRG | |
| SCHEMBL7511592 | 0.89 | RXRA (0.46) | PTGS2ALDH1A1LMNAMAPTPTGS1 | |
| SCHEMBL7502608 | 0.88 | PTGS2 (0.49) | PTGS2PTGS1RXRARXRBRXRG | |
| SCHEMBL7508070 | 0.87 | PTGS2 (0.43) | PTGS2ALDH1A1LMNAMAPTPTGS1 | |
| SCHEMBL7508189 | 0.87 | RXRA (0.54) | PTGS2ALDH1A1MAPTPTGS1RXRA | |
| SCHEMBL7511064 | 0.86 | PTGS2 (0.57) | PTGS2ALDH1A1LMNAMAPTPTGS1 | |
| SCHEMBL7507741 | 0.86 | PTGS2 (0.47) | PTGS2ALDH1A1LMNAMAPTPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0699192-B1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-07-24 | — | — | EP | disclosed |
| US-6090834-A | ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS | G.D. SEARLE & CO. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0825989-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-03-04 | — | — | EP | disclosed |
| US-5719163-A | ARTHRITIS | G.D. SEARLE & CO. (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1996036617-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0699192-A1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027980-A1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1994-12-08 | — | — | WO | disclosed |